Item 8.01. Other Events.
On September 27, 2021, the Company issued a press
release announcing entry into a global commercial contract with MySugarWatch DuoPack Limited, its UK licensee. The press release is attached
hereto as Exhibit 99.2 and, except with regard to the websites referenced therein, is incorporated herein by reference.
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
Certain statements contained in this Current Report
on Form 8-K, including on Exhibits 99.1 and 99.2 hereto, that are not historical facts constitute forward-looking statements, within the
meaning of the Private Securities Litigation Reform Act of 1995. Reliance should not be placed on forward-looking statements because they
involve known and unknown risks, uncertainties, and other factors, which may cause actual results, performance, or achievements to differ
materially from those expressed or implied. Any forward-looking statement speaks only as of the date made. We undertake no obligation
to update any forward-looking statements to reflect events or circumstances after the date on which they are made.
The words "believe," "anticipate,"
"design," "estimate," "plan," "predict," "seek," "expect," "intend,"
"may," "could," "should," "potential," "likely," "projects," "continue,"
"will," and "would" and similar expressions are intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words. These forward-looking statements are not guarantees of the future as there
are a number of meaningful factors that could cause the Company’s actual results to vary materially from those indicated by such
forward-looking statements. These statements are based on certain assumptions made based on experience, expected future developments and
other factors the Company believes are appropriate in the circumstances. Factors which could cause actual results to differ from expectations,
many of which are beyond the Company’s control, include, but are not limited to, obtaining regulatory approval for our sugarBEAT
device, conducting successful clinical trials, executing agreements required to successfully advance the Company's objectives; retaining
the management and scientific team to advance the product; overcoming adverse changes in market conditions and the regulatory environment;
obtaining and enforcing intellectual property rights; obtaining adequate financing in the future through product licensing, public or
private equity or debt financing or otherwise; dealing with general business conditions and competition; and other factors referenced
in the Company’s filings with the Securities and Exchange Commission, including in the “Risk Factors” section of the
Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, as the same may be updated from time to time. Except
as required by law, we do not assume any obligation to update any forward-looking statement. We disclaim any intention or obligation to
update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.